Exogenus Therapeutics

📍 Cantanhede, Portugal🗓 Founded 2015👥 11 employees💰 Last funded Dec 2015
Biotechnology🌐 exogenus-t.com
Website LinkedIn
Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for the treatment of severe lung inflammation, a condition with limited treatment options and a common cause of death following SARS‑CoV‑2 infection. Contact us at team@exogenus-t.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in Exogenus Therapeutics?
Exogenus Therapeutics has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Exogenus Therapeutics last raise funding?
The most recent investment in Exogenus Therapeutics recorded on gritt.io was in December 2015.
When was Exogenus Therapeutics founded?
Exogenus Therapeutics was founded in 2015.
What industry is Exogenus Therapeutics in?
Exogenus Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Exogenus Therapeutics based?
Exogenus Therapeutics is headquartered in Cantanhede, Portugal.